MGMaría José Gallardo

María José Gallardo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


María José Gallardo has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of COVID-19 Infection on the Immune Response to the SARS-CoV-2 Vaccine in Rheumatoid Patients

    by Maria Jose Gallardo-Nelson, Yolanda Gómez, Javiera Del Villar, Fernanda Zapata

    Rheumatic diseases affect the musculoskeletal system and may also compromise internal organs. The immunosuppressive treatments commonly used in these conditions can weaken the immune system, raising concerns about the efficacy of immunizations, particularly against SARS-CoV-2. This observational and analytical study evaluated the humoral immune response in patients with rheumatic diseases who were vaccinated with a fourth dose of the SARS-CoV-2 vaccine in comparison with a control group and the effect prior COVID-19 infection. The results showed that individuals with a history of COVID-19 infection developed significantly higher levels of neutralizing antibody titers, indicating a stronger immune response. Moreover, the response on the Wuhan strain elicited a more robust humoral response than the Omicron strain in both immunocompromised patients and healthy controls. These findings highlight the impact of previous viral exposure on the effectiveness of immunization in rheumatology patients.

  • Open Access

    4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients

    by Maria Jose Gallardo-Nelson, Marcos Cruces, Yolanda M. Gómez, Constanza Fuenzalida, Javiera Silva, Laura Aravena-Traipi, Eduardo Nuñez, Aracelly Gaete-Angel, Elizabeth Rivas-Yañez, Alexis M. Kalergis, et al.

    Objective: to evaluate the immune response to the SARS-CoV-2 vaccines in adults with immune-mediated rheumatic diseases (IMRDs) in comparison to healthy individuals, observed 1-20 weeks following the fourth vaccine dose. Additionally, to evaluate the impact of immunosuppressive therapies, vaccination schedules, the time interval between vaccination and sample collection on the vaccine’s immune response.Methods: We designed a longitudinal observational study conducted at the rheumatology department of Hospital de Copiapó. Neutralizing antibodies (Nabs) titers against the Wuhan and Omicron variant were analyzed between 1-20 weeks after administration of the fourth dose of the SARS-CoV-2 vaccine to 341 participants (218 IMRD patients and 123 healthy controls). 218 IMRD patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), systemic vasculitis (VS) and systemic scleroderma (SS) were analyzed.Results: Performing a comparison between the variants, Wuhan vs Omicron, we noticed that there were significant differences (p50, both for healthy controls and for patients with IMRDs. The humoral response of patients with IMRDs is significantly lower compared to healthy controls for the Omicron variant of SARS-CoV-2 (p = 0.0015). The humoral response of patients with IMRDs decreases significantly when the time interval between vaccination and sample collection is greater than 35 days. This difference was observed in the response, both for the Wuhan variant and for the Omicron variant.Conclusion: The IMRDs patients, the humoral response variation in the SARS-CoV-2 vaccine depends on doses and type of vaccine administered, the humoral response times and the treatment that these patients are receiving.


  • Open Access

    The Slash Half-Normal Distribution Applied to a Cure Rate Model with Application to Bone Marrow Transplantation

    by Diego I. Gallardo, Yolanda M. Gómez, Héctor J. Gómez, María José Gallardo-Nelson, Marcelo Bourguignon

    This paper proposes, for the first time, the use of an asymmetric positive and heavy-tailed distribution in a cure rate model context. In particular, it introduces a cure-rate survival model by assuming that the time-to-event of interest follows a slash half-normal distribution and that the number of competing causes of the event of interest follows a power series distribution, which defines six new cure rate models. Several properties of the model are derived and an alternative expression for the cumulative distribution function of the model is presented, which is very useful for the computational implementation of the model. A procedure based on the expectation–maximization algorithm is proposed for the parameter estimation. Two simulation studies are performed to assess some properties of the estimators, showing the good performance of the proposed estimators in finite samples. Finally, an application to a bone marrow transplant data set is presented.


  • Open Access

    Use of Cocktail of Bacteriophage for Salmonella Typhimurium Control in Chicken Meat

    by Matías Aguilera, Sofía Martínez, Mario Tello, María José Gallardo, Verónica García

    Foodborne diseases are extremely relevant and constitute an area of alert for public health authorities due to the high impact and number of people affected each year. The food industry has implemented microbiological control plans that ensure the quality and safety of its products; however, due to the high prevalence of foodborne diseases, the industry requires new microbiological control systems. One of the main causative agents of diseases transmitted by poultry meat is the bacterium Salmonella enterica. Disinfectants, antibiotics, and vaccines are used to control this pathogen. However, they have not been efficient in the total elimination of these bacteria, with numerous outbreaks caused by this bacterium observed today, in addition to the increase in antibiotic-resistant bacteria. The search for new technologies to reduce microbial contamination in the poultry industry continues to be a necessity and the use of lytic bacteriophages is one of the new solutions. In this study, 20 bacteriophages were isolated for Salmonella spp. obtained from natural environments and cocktails composed of five of them were designed, where three belonged to the Siphoviridae family and two to the Microviridae family. This cocktail was tested on chicken meat infected with Salmonella Typhimurium at 10 °C, where it was found that this cocktail was capable of decreasing 1.4 logarithmic units at 48 h compared to the control.


  • Open Access

    Protective Role of a Donepezil-Huprine Hybrid against the β-Amyloid (1-42) Effect on Human Erythrocytes

    by Pablo Zambrano, Mario Suwalsky, Malgorzata Jemiola-Rzeminska, María José Gallardo-Nelson, Kazimierz Strzalka, Diego Muñoz-Torrero

    Aβ(1-42) peptide is a neurotoxic agent strongly associated with the etiology of Alzheimer’s disease (AD). Current treatments are still of very low effectiveness, and deaths from AD are increasing worldwide. Huprine-derived molecules have a high affinity towards the enzyme acetylcholinesterase (AChE), act as potent Aβ(1-42) peptide aggregation inhibitors, and improve the behavior of experimental animals. AVCRI104P4 is a multitarget donepezil-huprine hybrid that improves short-term memory in a mouse model of AD and exerts protective effects in transgenic Caenorhabditis elegans that express Aβ(1-42) peptide. At present, there is no information about the effects of this compound on human erythrocytes. Thus, we considered it important to study its effects on the cell membrane and erythrocyte models, and to examine its protective effect against the toxic insult induced by Aβ(1-42) peptide in this cell and models. This research was developed using X-ray diffraction and differential scanning calorimetry (DSC) on molecular models of the human erythrocyte membrane constituted by lipid bilayers built of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE). They correspond to phospholipids representative of those present in the external and internal monolayers, respectively, of most plasma and neuronal membranes. The effect of AVCRI104P4 on human erythrocyte morphology was studied by scanning electron microscopy (SEM). The experimental results showed a protective effect of AVCRI104P4 against the toxicity induced by Aβ(1-42) peptide in human erythrocytes and molecular models.


  • The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes

    by Pablo Zambrano, Mario Suwalsky, Malgorzata Jemiola-Rzeminska, Kazimierz Strzalka, Benjamin Sepúlveda, María J. Gallardo, Luis F. Aguilar


  • Antioxidant effect of resveratrol in single red blood cells measured by thermal fluctuation spectroscopy

    by María José Gallardo, Mario Suwalsky, Diego Ramírez, Jorge Tapia, Benjamín Sepulveda


  • In vitro effects of benzimidazole/thioether-copper complexes with antitumor activity on human erythrocytes

    by Mario Suwalsky, Ivan Castillo, Brenda N. Sánchez-Eguía, María José Gallardo, Nathan Dukes, Edelmiro Santiago-Osorio, Itzen Aguiñiga, Ana R. Rivera-Martínez


  • Effects of Thimerosal on Lipid Bilayers and Human Erythrocytes: An In Vitro Study

    by Mario Suwalsky, Pablo Zambrano, María José Gallardo, Fernando Villena, Malgorzata Jemiola-Rzeminska, Kazimierz Strzalka

    Thimerosal (THI, ethyl-mercury thiosalicylate) is added to vaccines as a preservative; as a consequence, infants may have been exposed to bolus doses of Hg that collectively added up to nominally 200 µg Hg during the first 6 months of life. While several studies report an association between THI-containing vaccines and neurological disorders, other studies do not support the causal relation between THI and autism. With the purpose to understand the molecular mechanisms of the toxic effect of THI it was assayed on human red cells and in bilayers built-up of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE), classes of phospholipids found in the outer and inner monolayers of the human erythrocyte membrane, respectively. The capacity of THI to interact with DMPC and DMPE was determined by X-ray diffraction and differential scanning calorimetry, whereas intact human erythrocytes were observed by optical, defocusing and scanning electron microscopy. The experimental findings of this study demonstrated that THI interacted in a concentration-dependent manner with DMPC and DMPE bilayers, and in vitro interacted with erythrocytes inducing morphological changes. However, concentrations were considerable higher than those present in vaccines.